Evaluation of the efficacy of RF microneedling and oral isotretinoin in comparison with oral isotretionoin alone in the treatment of acne vulgaris

Introduction:
Acne vulgaris is one of the most common skin illnesses in teenagers, affecting 80% of people aged 11–30 years. Scars on the face are caused by high inflammation, severe acne, physical manipulation of the skin, and delayed treatment.

Aim:
To compare the effectiveness and safety of an automated RF micro needlingn device and oral isotretinoin with oral isotretinon alone alone for treating active acne.

Material and methods:
A cross-sectional study of 40 moderate acne sufferers. Twenty patients with active acne were treated with an automated RF microneedling device and isotretinoin 0.5–1 mg/kg. Group B included 20 people with active acne, who were given a single dose of 0.5–1 mg/kg isotretinoin.

Results:
In this cross-sectional research, 40 acne vulgaris patients were divided into 2 groups: group A: 23.8 ±3.2 years old, 58.95 ±5.5 kg, 13 females, and 7 males. There were 15 females and 5 males in group B: 24.4 ±3.7 years old and weighing 56.4 ±8.46 kg. After 12 weeks, group A shows better global acne assessment scale (GAAS) outcomes than group B than group B. After 6 months, group A showed better results than group B. The GAAS meaning global acne assessment scale did not change after 4–8 weeks of treatment. There was no age or weight difference.

Conclusions:
Acne vulgaris may be treated with fractional RF microneedling. Active acne treatment with RF microneedling is safe and effective, has a quicker response, causes less scarring, and reduces recurrence.